Trading Signals: ADMA Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Tue. Nov. 5, 2019)(ADMA Biologics Inc)
| ADMA latest price $5.2400 (2.54%) ($5.0100 - $5.2400) on Wed. Apr. 10, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.95% (three month average) | RSI | 79 | Latest Price | $5.2400(2.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ADMA advances 0.4% a day on average for past five trading days. | Weekly Trend | ADMA advances 22.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ADMA advance at 0% a week (0% probability) VWO(36%) USO(22%) VXX(-12%) TBT(62%) TIP(-9%) | Factors Impacting ADMA price | ADMA will decline at least -2.975% in a week (0% probabilities). JETS(22%) KWEB(55%) LQD(-20%) EWY(33%) EEM(41%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.975% (StdDev 5.95%) | Hourly BBV | 0 () | Intraday Trend | 3.8% | | | |
|
5 Day Moving Average | $5.15(1.75%) | 10 Day Moving Average | $4.74(10.55%) | 20 Day Moving Average | $4.24(23.58%) | To recent high | 0% | To recent low | 3.6% | Market Cap | $452m | | | | ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in the manufacturing, marketing and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment comprises of the immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ. |